Cancer Drug Delivery in the Nano Era
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 261
Special Issue Editors
Interests: nanomedicine; phototherapy; radio-immunotherapy
Interests: investigating how targeting innate sensing pathways reinvigorates the tumor microenvironment and enhances radiation therapy and immunotherapy
Interests: surfactants; polymers and nanoparticles in solution; nanocarriers for controlled and targeted release of drugs; materials with drug-device functions; small angle scattering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The unique physicochemical properties of nanosized materials have led to their incorporation into a wide range of biomedical applications. This includes uses in drug delivery, cancer photo/chemo/radio/immuno therapy, and materials for cancer imaging (fluorescence/photoacoustic/ultrasonic/MRI/PET imaging), to name but a few examples. The understanding and optimization of their properties require the development of multi-scale and multi-discipline approaches. Nowadays, with rapid and extensive improvements in nanotechnology, different types of nanomaterials (inorganic, organic, or hybrid) are the fundamental building blocks to rationalize the design of compounds for targeted biomedical applications; for instance, application in cancer drug delivery was one of the pioneering uses of these methods for nanomedicines. This Special Issue aims to provide an overview that focuses on “Cancer Drug Delivery in the Nano Era”, constituting an open forum where researchers may share their investigations, findings, and opinions in this promising field. Contributions to this Special Issue, both in the form of original research works or review articles, should cover all aspects of biomedical applications of inorganic/organic/hybrid nanoparticles for cancer drug delivery, therapy, imaging, or pharmaceutics. Studies with multidisciplinary input, offering new methodologies or insights, are particularly welcome.
Dr. Dapeng Chen
Dr. Kaiting Yang
Dr. Vasyl M. Haramus
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicines
- drug delivery
- cancer therapy
- cancer imaging
